CAS: 898826-64-7 - (2R,3S,4S,5R,6S)-2-[(2S,3R,4R,5S,6S)-6-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-methoxyphenoxy)tetrahydropyran-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
Formula:C25H38O17
InChI:InChI=1/C25H38O17/c1-36-9-2-4-10(5-3-9)37-23-19(34)16(31)21(12(7-27)39-23)42-25-20(35)17(32)22(13(8-28)40-25)41-24-18(33)15(30)14(29)11(6-26)38-24/h2-5,11-35H,6-8H2,1H3/t11-,12-,13-,14-,15-,16+,17+,18-,19-,20-,21+,22-,23+,24+,25-/m0/s1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Gb3-β-MP REF: 3B-M1767CAS: 898826-64-7 | >95.0%(HPLC) | 174.00 € | Mon 30 Dec 24 | |
Gb3-β-MP REF: IN-DA003QQOCAS: 898826-64-7 | >95.0%(HPLC) | To inquire | Tue 07 Jan 25 | |
Gb3-²-MP REF: 3D-YKB82664CAS: 898826-64-7 | Min. 95% | To inquire | Tue 18 Feb 25 |
Gb3-β-MP
CAS:898826-64-7
Formula:
C25H38O17
Purity:
>95.0%(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
610.56
- Building Blocks
- Glycoscience
- Sphingolipids
- Primary Antibodies
- See more categories
- Glycosides
- Glycolipids
- Galactose
- Trisaccharides and Above
- Oligosaccharides by Component Sugar
- Protected Sugars
- Sugar Building Blocks by Target Oligosaccharides
- Sphingoglycolipids
- Functional Oligosaccharides
- Globo- and Isoglobo-series
- Blood Type Oligosaccharides
- Sugar Antigens
- Glyco-Related Antibodies
- Cancer Research
- Biochemicals and Reagents
Ref: 3B-M1767
100mg | 174.00 € |
Estimated delivery in United States, on Monday 30 Dec 2024
Gb3-β-MP
CAS:898826-64-7
Formula:
C25H38O17
Purity:
>95.0%(HPLC)
Color and Shape:
Solid
Molecular weight:
610.5590
Ref: IN-DA003QQO
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Gb3-²-MP
CAS:898826-64-7
Please enquire for more information about Gb3-²-MP including the price, delivery time and more detailed …
Formula:
C25H38O17
Purity:
Min. 95%
Molecular weight:
610.56 g/mol
Ref: 3D-YKB82664
500mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025